RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain. Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC 82009-032-10

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
July 25, 2025
Posted
August 20, 2025
Recall Number
D-0580-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,856 bottles
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

Distribution

NJ, AZ, IN

Lot / Code Info

Lot 240539C, Exp 1/31/2027

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls